What is Mal de Debarquement Syndrome (MdDS)?
MdDS is a rare and life-altering balance disorder that most commonly develops after an ocean cruise or other type of water travel. MdDS is also known as disembarkment disease or persistent landsickness. MdDS also occurs following air/train travel or other motion experiences or spontaneously/in the absence of a motion event. MdDS is a syndrome because it often includes a diverse array of symptoms. The characteristic symptom of MdDS is a persistent sensation of motion such as rocking, swaying and/or bobbing.
Other MdDS Symptoms:
• Disequilibrium -a sensation of unsteadiness or loss of balance 
How long will it last?
Many people transiently experience sensations of floating or imbalance after a cruise or other motion experience. However, these sensations usually continue for only a few hours or days. This is more commonly referred to as "landsickness" or "regaining your land legs." In striking contrast, these symptoms persist for months to years with MdDS. MdDS symptoms may or may not diminish over time and may reoccur following another motion experience or during periods of stress or illness.
The cause of MdDS is unknown. The majority (~90%) with MdDS are women, but no hormonal connection has been identified. Some believe that MdDS is a variant of motion sickness and related to inappropriate vestibular adaptation after a motion experience. Another theory is that it is a variant of migraine. More biomedical research is needed.
What are treatment options?
Most anticholinergic or antiemetic medications that work for other forms of dizziness or motion sickness, such as scopolamine and meclizine, are not effective in either the prevention or treatment of MdDS.
While there is no known cure, there is evidence that benzodiazepines and amitriptyline have had positive effects in the treatment of MdDS. Additionally, some patients benefit from vestibular therapy and exercise.
Rigorous clinical studies have not been performed to examine the prevention of MdDS through the use of medication. Nevertheless, some MdDS patients who travel utilize benzodiazepines prior to and during travel to keep MdDS symptoms in check.
An increased awareness among physicians may help lead to the clinical knowledge necessary to develop effective treatment strategies. Further research is required to gain a greater understanding of this disorder.
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